Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 39.36.

  • Molecular Partners Ag's Asset Utilization Ratio rose 10477.44% to 39.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 39.36, marking a year-over-year increase of 10477.44%. This contributed to the annual value of 28.15 for FY2024, which is 8843454276.99% up from last year.
  • Molecular Partners Ag's Asset Utilization Ratio amounted to 39.36 in Q3 2025, which was up 10477.44% from 37.16 recorded in Q2 2025.
  • Molecular Partners Ag's Asset Utilization Ratio's 5-year high stood at 1284046.54 during Q3 2022, with a 5-year trough of 2.11 in Q1 2024.
  • Over the past 5 years, Molecular Partners Ag's median Asset Utilization Ratio value was 6556.25 (recorded in 2023), while the average stood at 242780.46.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 178255676.89% in 2022, then plummeted by 9998.38% in 2024.
  • Over the past 5 years, Molecular Partners Ag's Asset Utilization Ratio (Quarter) stood at 37.3 in 2021, then soared by 1782556.77% to 664934.91 in 2022, then tumbled by 97.89% to 14017.48 in 2023, then tumbled by 99.71% to 41.35 in 2024, then decreased by 4.82% to 39.36 in 2025.
  • Its last three reported values are 39.36 in Q3 2025, 37.16 for Q2 2025, and 43.91 during Q1 2025.